

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | exogenous drug catabolic process (GO:0042738) | 9.99181116 |
| 2 | drug catabolic process (GO:0042737) | 9.39490781 |
| 3 | regulation of fibrinolysis (GO:0051917) | 8.06852267 |
| 4 | negative regulation of fibrinolysis (GO:0051918) | 7.96138666 |
| 5 | glyoxylate metabolic process (GO:0046487) | 7.77418527 |
| 6 | epoxygenase P450 pathway (GO:0019373) | 7.72661961 |
| 7 | omega-hydroxylase P450 pathway (GO:0097267) | 7.57439818 |
| 8 | L-phenylalanine catabolic process (GO:0006559) | 7.56129465 |
| 9 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.56129465 |
| 10 | regulation of protein activation cascade (GO:2000257) | 6.97294620 |
| 11 | complement activation, alternative pathway (GO:0006957) | 6.94491279 |
| 12 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.82256694 |
| 13 | L-phenylalanine metabolic process (GO:0006558) | 6.82256694 |
| 14 | regulation of complement activation (GO:0030449) | 6.54358181 |
| 15 | fibrinolysis (GO:0042730) | 6.51662432 |
| 16 | cellular glucuronidation (GO:0052695) | 6.49870732 |
| 17 | oxidative demethylation (GO:0070989) | 6.27187248 |
| 18 | glucuronate metabolic process (GO:0019585) | 6.18597774 |
| 19 | uronic acid metabolic process (GO:0006063) | 6.18597774 |
| 20 | negative regulation of cholesterol transport (GO:0032375) | 6.14397613 |
| 21 | negative regulation of sterol transport (GO:0032372) | 6.14397613 |
| 22 | aromatic amino acid family catabolic process (GO:0009074) | 6.11954196 |
| 23 | drug metabolic process (GO:0017144) | 6.04299906 |
| 24 | bile acid biosynthetic process (GO:0006699) | 6.03126418 |
| 25 | peptidyl-glutamic acid carboxylation (GO:0017187) | 6.00205986 |
| 26 | protein carboxylation (GO:0018214) | 6.00205986 |
| 27 | urea metabolic process (GO:0019627) | 5.94598629 |
| 28 | blood coagulation, intrinsic pathway (GO:0007597) | 5.76811300 |
| 29 | serine family amino acid catabolic process (GO:0009071) | 5.63538522 |
| 30 | ethanol oxidation (GO:0006069) | 5.54633889 |
| 31 | nitrogen cycle metabolic process (GO:0071941) | 5.43357301 |
| 32 | bile acid metabolic process (GO:0008206) | 5.33177916 |
| 33 | phenylpropanoid metabolic process (GO:0009698) | 5.32584166 |
| 34 | regulation of triglyceride catabolic process (GO:0010896) | 5.32320521 |
| 35 | S-adenosylmethionine metabolic process (GO:0046500) | 5.28577776 |
| 36 | regulation of plasminogen activation (GO:0010755) | 5.16332435 |
| 37 | glycine metabolic process (GO:0006544) | 5.10345287 |
| 38 | amino-acid betaine metabolic process (GO:0006577) | 5.02670586 |
| 39 | indole-containing compound catabolic process (GO:0042436) | 4.83798401 |
| 40 | indolalkylamine catabolic process (GO:0046218) | 4.83798401 |
| 41 | tryptophan catabolic process (GO:0006569) | 4.83798401 |
| 42 | negative regulation of hemostasis (GO:1900047) | 4.80032479 |
| 43 | negative regulation of blood coagulation (GO:0030195) | 4.80032479 |
| 44 | urea cycle (GO:0000050) | 4.79260812 |
| 45 | acylglycerol homeostasis (GO:0055090) | 4.74145764 |
| 46 | triglyceride homeostasis (GO:0070328) | 4.74145764 |
| 47 | bile acid and bile salt transport (GO:0015721) | 4.74071294 |
| 48 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.73722833 |
| 49 | alkaloid metabolic process (GO:0009820) | 4.67534171 |
| 50 | protein activation cascade (GO:0072376) | 4.50677421 |
| 51 | tyrosine metabolic process (GO:0006570) | 4.44512790 |
| 52 | ethanol metabolic process (GO:0006067) | 4.42162681 |
| 53 | phospholipid efflux (GO:0033700) | 4.38520450 |
| 54 | negative regulation of coagulation (GO:0050819) | 4.36123594 |
| 55 | response to mercury ion (GO:0046689) | 4.31686916 |
| 56 | negative regulation of protein activation cascade (GO:2000258) | 4.27663414 |
| 57 | negative regulation of wound healing (GO:0061045) | 4.27075554 |
| 58 | flavonoid metabolic process (GO:0009812) | 4.23728916 |
| 59 | high-density lipoprotein particle remodeling (GO:0034375) | 4.16362031 |
| 60 | imidazole-containing compound metabolic process (GO:0052803) | 4.14442239 |
| 61 | intestinal cholesterol absorption (GO:0030299) | 4.14294815 |
| 62 | fat-soluble vitamin biosynthetic process (GO:0042362) | 4.12423244 |
| 63 | protein-lipid complex remodeling (GO:0034368) | 4.12217890 |
| 64 | macromolecular complex remodeling (GO:0034367) | 4.12217890 |
| 65 | plasma lipoprotein particle remodeling (GO:0034369) | 4.12217890 |
| 66 | regulation of humoral immune response (GO:0002920) | 4.11865551 |
| 67 | acute-phase response (GO:0006953) | 4.11770225 |
| 68 | aromatic amino acid family metabolic process (GO:0009072) | 4.11553917 |
| 69 | positive regulation of blood coagulation (GO:0030194) | 4.09120356 |
| 70 | positive regulation of hemostasis (GO:1900048) | 4.09120356 |
| 71 | serine family amino acid metabolic process (GO:0009069) | 4.07431469 |
| 72 | tryptophan metabolic process (GO:0006568) | 4.06403851 |
| 73 | complement activation, classical pathway (GO:0006958) | 4.05975670 |
| 74 | complement activation (GO:0006956) | 4.04867238 |
| 75 | arginine metabolic process (GO:0006525) | 4.04550952 |
| 76 | L-methionine salvage (GO:0071267) | 4.04446936 |
| 77 | L-methionine biosynthetic process (GO:0071265) | 4.04446936 |
| 78 | amino acid salvage (GO:0043102) | 4.04446936 |
| 79 | negative regulation of lipase activity (GO:0060192) | 4.01927989 |
| 80 | cholesterol efflux (GO:0033344) | 4.01739997 |
| 81 | heme transport (GO:0015886) | 3.99125046 |
| 82 | alpha-amino acid catabolic process (GO:1901606) | 3.91995011 |
| 83 | cellular ketone body metabolic process (GO:0046950) | 3.85539460 |
| 84 | reverse cholesterol transport (GO:0043691) | 3.77322386 |
| 85 | positive regulation of coagulation (GO:0050820) | 3.75692654 |
| 86 | sodium-independent organic anion transport (GO:0043252) | 3.75434497 |
| 87 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.70630339 |
| 88 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.70630339 |
| 89 | aminoglycoside antibiotic metabolic process (GO:0030647) | 3.69779565 |
| 90 | polyketide metabolic process (GO:0030638) | 3.69059024 |
| 91 | doxorubicin metabolic process (GO:0044598) | 3.69059024 |
| 92 | daunorubicin metabolic process (GO:0044597) | 3.69059024 |
| 93 | regulation of cholesterol esterification (GO:0010872) | 3.65440166 |
| 94 | drug transmembrane transport (GO:0006855) | 3.60886000 |
| 95 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.59720088 |
| 96 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.58479960 |
| 97 | cytolysis (GO:0019835) | 3.54725736 |
| 98 | negative regulation of complement activation (GO:0045916) | 3.53714207 |
| 99 | * xenobiotic metabolic process (GO:0006805) | 3.52664952 |
| 100 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.52463764 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 8.73908049 |
| 2 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.09259767 |
| 3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.48979107 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.74244969 |
| 5 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.58138786 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.98346810 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.92704003 |
| 8 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.53832295 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.43983080 |
| 10 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.74120807 |
| 11 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.93365950 |
| 12 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.93037564 |
| 13 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.88710133 |
| 14 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.77974190 |
| 15 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.77464478 |
| 16 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.76845665 |
| 17 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.75020671 |
| 18 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.74237641 |
| 19 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.61968552 |
| 20 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.55635197 |
| 21 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.47919301 |
| 22 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.46108316 |
| 23 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.45854687 |
| 24 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.43742629 |
| 25 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.43480059 |
| 26 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.39192339 |
| 27 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.36551267 |
| 28 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.33013111 |
| 29 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.26215228 |
| 30 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.26024293 |
| 31 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.25589482 |
| 32 | VDR_22108803_ChIP-Seq_LS180_Human | 1.24588461 |
| 33 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.22944142 |
| 34 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.19830230 |
| 35 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.19667205 |
| 36 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.18735465 |
| 37 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.18404911 |
| 38 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.18192414 |
| 39 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.18192414 |
| 40 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.14575198 |
| 41 | AR_20517297_ChIP-Seq_VCAP_Human | 1.12103082 |
| 42 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.12081719 |
| 43 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.11481096 |
| 44 | * CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.10649610 |
| 45 | * KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.10433553 |
| 46 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.10112105 |
| 47 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.10006014 |
| 48 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.09125631 |
| 49 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.08409507 |
| 50 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.07816014 |
| 51 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.05691271 |
| 52 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 1.04318338 |
| 53 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.03926375 |
| 54 | PHF8_20622853_ChIP-Seq_HELA_Human | 1.03533217 |
| 55 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.03057112 |
| 56 | CBP_21632823_ChIP-Seq_H3396_Human | 1.02821281 |
| 57 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.01450816 |
| 58 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.01223791 |
| 59 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.00769951 |
| 60 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.00769951 |
| 61 | NFYA_21822215_ChIP-Seq_K562_Human | 0.99752638 |
| 62 | TCF4_23295773_ChIP-Seq_U87_Human | 0.98696774 |
| 63 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.98206320 |
| 64 | P300_19829295_ChIP-Seq_ESCs_Human | 0.98189925 |
| 65 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.97934358 |
| 66 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.97918388 |
| 67 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.97513342 |
| 68 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.96068048 |
| 69 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.95738941 |
| 70 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.95662494 |
| 71 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.94668415 |
| 72 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.94640781 |
| 73 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.94597840 |
| 74 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.94267467 |
| 75 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.94147082 |
| 76 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.93041437 |
| 77 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.91512247 |
| 78 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.91315404 |
| 79 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.91088874 |
| 80 | ETV1_20927104_ChIP-Seq_GIST48_Human | 0.89350443 |
| 81 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.89208360 |
| 82 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.87899217 |
| 83 | CBX2_22325352_ChIP-Seq_293T-Rex_Human | 0.87168036 |
| 84 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.86977298 |
| 85 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.86767766 |
| 86 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.86767766 |
| 87 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.86566051 |
| 88 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.86415370 |
| 89 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.85601321 |
| 90 | NCOR_22424771_ChIP-Seq_293T_Human | 0.85211055 |
| 91 | AR_25329375_ChIP-Seq_VCAP_Human | 0.84437190 |
| 92 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.83983786 |
| 93 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.83975911 |
| 94 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.83182134 |
| 95 | P300_18555785_Chip-Seq_ESCs_Mouse | 0.82867711 |
| 96 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.82853767 |
| 97 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.82853767 |
| 98 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.82829264 |
| 99 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.82325225 |
| 100 | NFYB_21822215_ChIP-Seq_K562_Human | 0.82156896 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 9.61763685 |
| 2 | MP0003195_calcinosis | 6.38855344 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.11515112 |
| 4 | MP0005365_abnormal_bile_salt | 5.71285924 |
| 5 | MP0005360_urolithiasis | 5.63054262 |
| 6 | MP0008875_abnormal_xenobiotic_pharmacok | 5.34474046 |
| 7 | MP0002138_abnormal_hepatobiliary_system | 4.63826636 |
| 8 | MP0003252_abnormal_bile_duct | 4.49296190 |
| 9 | MP0001666_abnormal_nutrient_absorption | 3.16672182 |
| 10 | MP0003868_abnormal_feces_composition | 3.02292507 |
| 11 | MP0010329_abnormal_lipoprotein_level | 2.82797733 |
| 12 | MP0009697_abnormal_copulation | 2.59395273 |
| 13 | MP0005332_abnormal_amino_acid | 2.52158522 |
| 14 | MP0002876_abnormal_thyroid_physiology | 2.20182827 |
| 15 | MP0009840_abnormal_foam_cell | 2.04545239 |
| 16 | MP0003806_abnormal_nucleotide_metabolis | 1.87776713 |
| 17 | MP0001764_abnormal_homeostasis | 1.69978736 |
| 18 | MP0000609_abnormal_liver_physiology | 1.69917113 |
| 19 | MP0002118_abnormal_lipid_homeostasis | 1.69129642 |
| 20 | MP0003191_abnormal_cellular_cholesterol | 1.47485477 |
| 21 | MP0010368_abnormal_lymphatic_system | 1.31205068 |
| 22 | MP0004019_abnormal_vitamin_homeostasis | 1.30146828 |
| 23 | MP0009643_abnormal_urine_homeostasis | 1.20751050 |
| 24 | MP0004043_abnormal_pH_regulation | 1.19317967 |
| 25 | MP0005408_hypopigmentation | 1.18348598 |
| 26 | MP0005319_abnormal_enzyme/_coenzyme | 1.14115321 |
| 27 | MP0005670_abnormal_white_adipose | 1.05562572 |
| 28 | MP0001661_extended_life_span | 1.01715352 |
| 29 | MP0005636_abnormal_mineral_homeostasis | 0.97817582 |
| 30 | MP0003011_delayed_dark_adaptation | 0.97583986 |
| 31 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.96771557 |
| 32 | MP0009053_abnormal_anal_canal | 0.96123001 |
| 33 | MP0000598_abnormal_liver_morphology | 0.93052749 |
| 34 | MP0002168_other_aberrant_phenotype | 0.92231551 |
| 35 | MP0003656_abnormal_erythrocyte_physiolo | 0.90270615 |
| 36 | MP0005395_other_phenotype | 0.90229446 |
| 37 | MP0008872_abnormal_physiological_respon | 0.89119400 |
| 38 | MP0009642_abnormal_blood_homeostasis | 0.84520427 |
| 39 | MP0009764_decreased_sensitivity_to | 0.81836591 |
| 40 | MP0005376_homeostasis/metabolism_phenot | 0.81774192 |
| 41 | MP0003879_abnormal_hair_cell | 0.80653171 |
| 42 | MP0003186_abnormal_redox_activity | 0.76157474 |
| 43 | MP0002971_abnormal_brown_adipose | 0.75765683 |
| 44 | MP0002132_abnormal_respiratory_system | 0.73237673 |
| 45 | MP0001756_abnormal_urination | 0.72383249 |
| 46 | MP0008469_abnormal_protein_level | 0.71497244 |
| 47 | MP0003638_abnormal_response/metabolism_ | 0.68942612 |
| 48 | MP0009763_increased_sensitivity_to | 0.68162113 |
| 49 | MP0005187_abnormal_penis_morphology | 0.67540075 |
| 50 | MP0002282_abnormal_trachea_morphology | 0.66271308 |
| 51 | MP0005535_abnormal_body_temperature | 0.65898520 |
| 52 | MP0005266_abnormal_metabolism | 0.63692133 |
| 53 | MP0005084_abnormal_gallbladder_morpholo | 0.63104164 |
| 54 | MP0002078_abnormal_glucose_homeostasis | 0.62742815 |
| 55 | MP0002928_abnormal_bile_duct | 0.59011424 |
| 56 | MP0001915_intracranial_hemorrhage | 0.56782533 |
| 57 | MP0005551_abnormal_eye_electrophysiolog | 0.56285295 |
| 58 | MP0000604_amyloidosis | 0.54097714 |
| 59 | MP0005646_abnormal_pituitary_gland | 0.53924487 |
| 60 | MP0005464_abnormal_platelet_physiology | 0.52116783 |
| 61 | MP0002136_abnormal_kidney_physiology | 0.51148069 |
| 62 | MP0003718_maternal_effect | 0.49812121 |
| 63 | MP0003690_abnormal_glial_cell | 0.48963743 |
| 64 | MP0005334_abnormal_fat_pad | 0.48881923 |
| 65 | MP0006036_abnormal_mitochondrial_physio | 0.47955031 |
| 66 | MP0005451_abnormal_body_composition | 0.47171269 |
| 67 | MP0005377_hearing/vestibular/ear_phenot | 0.45000031 |
| 68 | MP0003878_abnormal_ear_physiology | 0.45000031 |
| 69 | MP0004142_abnormal_muscle_tone | 0.43768009 |
| 70 | MP0005220_abnormal_exocrine_pancreas | 0.41643138 |
| 71 | MP0005647_abnormal_sex_gland | 0.41492516 |
| 72 | MP0005448_abnormal_energy_balance | 0.40778127 |
| 73 | MP0002249_abnormal_larynx_morphology | 0.40189160 |
| 74 | MP0008874_decreased_physiological_sensi | 0.39169902 |
| 75 | MP0003953_abnormal_hormone_level | 0.36789102 |
| 76 | MP0003646_muscle_fatigue | 0.35406571 |
| 77 | MP0004883_abnormal_blood_vessel | 0.34966948 |
| 78 | MP0004130_abnormal_muscle_cell | 0.32667061 |
| 79 | MP0000639_abnormal_adrenal_gland | 0.32328017 |
| 80 | MP0003959_abnormal_lean_body | 0.32094952 |
| 81 | MP0000249_abnormal_blood_vessel | 0.30215091 |
| 82 | MP0009115_abnormal_fat_cell | 0.29808387 |
| 83 | MP0001986_abnormal_taste_sensitivity | 0.29157228 |
| 84 | MP0009785_altered_susceptibility_to | 0.29154623 |
| 85 | MP0005164_abnormal_response_to | 0.29104257 |
| 86 | MP0010386_abnormal_urinary_bladder | 0.28681535 |
| 87 | MP0003633_abnormal_nervous_system | 0.28365835 |
| 88 | MP0005083_abnormal_biliary_tract | 0.26264445 |
| 89 | MP0000371_diluted_coat_color | 0.25917753 |
| 90 | MP0002909_abnormal_adrenal_gland | 0.25024850 |
| 91 | MP0001501_abnormal_sleep_pattern | 0.24693311 |
| 92 | MP0009765_abnormal_xenobiotic_induced | 0.24457689 |
| 93 | MP0002102_abnormal_ear_morphology | 0.24428337 |
| 94 | MP0005386_behavior/neurological_phenoty | 0.23774110 |
| 95 | MP0004924_abnormal_behavior | 0.23774110 |
| 96 | MP0003632_abnormal_nervous_system | 0.22646011 |
| 97 | MP0001324_abnormal_eye_pigmentation | 0.22191248 |
| 98 | MP0002135_abnormal_kidney_morphology | 0.22140094 |
| 99 | MP0008873_increased_physiological_sensi | 0.21947403 |
| 100 | MP0003631_nervous_system_phenotype | 0.21930626 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 9.53129784 |
| 2 | Deep venous thrombosis (HP:0002625) | 9.45182952 |
| 3 | Prolonged partial thromboplastin time (HP:0003645) | 8.78162760 |
| 4 | Complement deficiency (HP:0004431) | 8.18208932 |
| 5 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.74246561 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 7.68809550 |
| 7 | Conjugated hyperbilirubinemia (HP:0002908) | 6.46064060 |
| 8 | Abnormality of complement system (HP:0005339) | 6.41980744 |
| 9 | Joint hemorrhage (HP:0005261) | 5.99853174 |
| 10 | Hyperlipoproteinemia (HP:0010980) | 5.56820766 |
| 11 | Systemic lupus erythematosus (HP:0002725) | 5.47730095 |
| 12 | Intrahepatic cholestasis (HP:0001406) | 5.00470996 |
| 13 | Xanthomatosis (HP:0000991) | 4.70082910 |
| 14 | Glomerulonephritis (HP:0000099) | 4.49365633 |
| 15 | Abnormality of pyrimidine metabolism (HP:0004353) | 4.46496128 |
| 16 | Abnormality of the common coagulation pathway (HP:0010990) | 4.44982326 |
| 17 | Hypolipoproteinemia (HP:0010981) | 4.33973553 |
| 18 | Spontaneous abortion (HP:0005268) | 4.24925667 |
| 19 | Abnormality of the intrinsic pathway (HP:0010989) | 3.93843426 |
| 20 | Generalized aminoaciduria (HP:0002909) | 3.88363237 |
| 21 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.80237232 |
| 22 | Hyperglycinemia (HP:0002154) | 3.75274357 |
| 23 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.56542786 |
| 24 | Fat malabsorption (HP:0002630) | 3.52601223 |
| 25 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.51384167 |
| 26 | Nephritis (HP:0000123) | 3.43290876 |
| 27 | Rickets (HP:0002748) | 3.32695276 |
| 28 | Abnormality of glycine metabolism (HP:0010895) | 3.28124980 |
| 29 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.28124980 |
| 30 | Hyperglycinuria (HP:0003108) | 3.17579043 |
| 31 | Hyperammonemia (HP:0001987) | 3.10713973 |
| 32 | Abnormality of methionine metabolism (HP:0010901) | 3.09473774 |
| 33 | Steatorrhea (HP:0002570) | 2.94490933 |
| 34 | Vascular calcification (HP:0004934) | 2.93937792 |
| 35 | Delayed CNS myelination (HP:0002188) | 2.92624295 |
| 36 | Gingival bleeding (HP:0000225) | 2.85852127 |
| 37 | Abnormality of serum amino acid levels (HP:0003112) | 2.77767390 |
| 38 | Abnormality of nucleobase metabolism (HP:0010932) | 2.77311032 |
| 39 | Osteomalacia (HP:0002749) | 2.77158514 |
| 40 | Hypercholesterolemia (HP:0003124) | 2.77121655 |
| 41 | Mitral stenosis (HP:0001718) | 2.74657384 |
| 42 | Hypoalphalipoproteinemia (HP:0003233) | 2.72806649 |
| 43 | Epidermoid cyst (HP:0200040) | 2.70405158 |
| 44 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.69039655 |
| 45 | Fair hair (HP:0002286) | 2.68972928 |
| 46 | Abnormality of urine glucose concentration (HP:0011016) | 2.62399458 |
| 47 | Glycosuria (HP:0003076) | 2.62399458 |
| 48 | Hyperphosphaturia (HP:0003109) | 2.56964935 |
| 49 | Reduced antithrombin III activity (HP:0001976) | 2.56409670 |
| 50 | Cardiovascular calcification (HP:0011915) | 2.54355976 |
| 51 | Hemorrhage of the eye (HP:0011885) | 2.52704911 |
| 52 | Abnormality of vitamin metabolism (HP:0100508) | 2.41913062 |
| 53 | Thrombophlebitis (HP:0004418) | 2.40809399 |
| 54 | Alkalosis (HP:0001948) | 2.39640894 |
| 55 | Hyperbilirubinemia (HP:0002904) | 2.35158896 |
| 56 | Menorrhagia (HP:0000132) | 2.32554577 |
| 57 | Proximal tubulopathy (HP:0000114) | 2.26435314 |
| 58 | Ketosis (HP:0001946) | 2.24829147 |
| 59 | Pulmonary embolism (HP:0002204) | 2.23944509 |
| 60 | Metabolic acidosis (HP:0001942) | 2.22926751 |
| 61 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.22012127 |
| 62 | Hypophosphatemic rickets (HP:0004912) | 2.22009495 |
| 63 | Purpura (HP:0000979) | 2.21812101 |
| 64 | Hypochromic microcytic anemia (HP:0004840) | 2.17697874 |
| 65 | Arthropathy (HP:0003040) | 2.17005247 |
| 66 | Abnormal biliary tract physiology (HP:0012439) | 2.12576398 |
| 67 | Bile duct proliferation (HP:0001408) | 2.12576398 |
| 68 | Hepatocellular carcinoma (HP:0001402) | 2.06918795 |
| 69 | Bifid scrotum (HP:0000048) | 2.03121218 |
| 70 | Abnormality of purine metabolism (HP:0004352) | 1.99767863 |
| 71 | Abnormal urine phosphate concentration (HP:0012599) | 1.97007230 |
| 72 | Abnormality of proline metabolism (HP:0010907) | 1.97002279 |
| 73 | Hydroxyprolinuria (HP:0003080) | 1.97002279 |
| 74 | Enlarged kidneys (HP:0000105) | 1.96984284 |
| 75 | Irritability (HP:0000737) | 1.94841176 |
| 76 | Poikilocytosis (HP:0004447) | 1.90405001 |
| 77 | Generalized hypopigmentation of hair (HP:0011358) | 1.85674715 |
| 78 | Gout (HP:0001997) | 1.83968639 |
| 79 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.83573472 |
| 80 | Increased circulating renin level (HP:0000848) | 1.79526502 |
| 81 | Potter facies (HP:0002009) | 1.74969745 |
| 82 | Facial shape deformation (HP:0011334) | 1.74969745 |
| 83 | Lethargy (HP:0001254) | 1.72450505 |
| 84 | Joint swelling (HP:0001386) | 1.69487104 |
| 85 | Gangrene (HP:0100758) | 1.67469815 |
| 86 | Abnormal platelet function (HP:0011869) | 1.66571098 |
| 87 | Impaired platelet aggregation (HP:0003540) | 1.66571098 |
| 88 | Increased mean platelet volume (HP:0011877) | 1.66062475 |
| 89 | Elevated alkaline phosphatase (HP:0003155) | 1.65535701 |
| 90 | Cerebral palsy (HP:0100021) | 1.62141469 |
| 91 | Abnormal urine output (HP:0012590) | 1.62004246 |
| 92 | Cholelithiasis (HP:0001081) | 1.61932474 |
| 93 | Hypochromic anemia (HP:0001931) | 1.61326539 |
| 94 | Metabolic alkalosis (HP:0200114) | 1.60973334 |
| 95 | Neonatal hypoglycemia (HP:0001998) | 1.60585715 |
| 96 | Abnormal gallbladder morphology (HP:0012437) | 1.60413870 |
| 97 | Ketoacidosis (HP:0001993) | 1.60360594 |
| 98 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.60054007 |
| 99 | Hypokalemic alkalosis (HP:0001949) | 1.58187093 |
| 100 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.56332616 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 6.35916386 |
| 2 | WNK3 | 6.28926497 |
| 3 | OXSR1 | 3.32527240 |
| 4 | PIK3CG | 2.77088911 |
| 5 | TAOK3 | 2.63443825 |
| 6 | NTRK3 | 2.19968242 |
| 7 | ADRBK2 | 2.12937766 |
| 8 | PINK1 | 2.03081103 |
| 9 | MAP4K2 | 1.90723556 |
| 10 | INSRR | 1.90123169 |
| 11 | PIK3CA | 1.88711080 |
| 12 | GRK1 | 1.83675708 |
| 13 | ERN1 | 1.82026656 |
| 14 | ACVR1B | 1.81757970 |
| 15 | BCKDK | 1.70622422 |
| 16 | WNK4 | 1.65135627 |
| 17 | PRKCG | 1.53829084 |
| 18 | PRKAA2 | 1.53621451 |
| 19 | BCR | 1.50529652 |
| 20 | PRKACG | 1.44939488 |
| 21 | STK39 | 1.37834659 |
| 22 | NUAK1 | 1.36944643 |
| 23 | EPHA4 | 1.30988655 |
| 24 | FGFR4 | 1.28092119 |
| 25 | BMPR1B | 1.27059488 |
| 26 | SGK2 | 1.26676503 |
| 27 | CASK | 1.23396638 |
| 28 | EPHA3 | 1.21401004 |
| 29 | MAP2K4 | 1.19324323 |
| 30 | FER | 1.07816721 |
| 31 | MAPK13 | 1.06953000 |
| 32 | MAP3K4 | 1.06434987 |
| 33 | FGFR3 | 1.05301062 |
| 34 | TNK2 | 1.00709428 |
| 35 | TYK2 | 0.99838766 |
| 36 | SGK494 | 0.97923881 |
| 37 | SGK223 | 0.97923881 |
| 38 | MAPKAPK3 | 0.97819616 |
| 39 | MAPK11 | 0.97781556 |
| 40 | IGF1R | 0.97134695 |
| 41 | PRKAA1 | 0.96974619 |
| 42 | AKT3 | 0.90476358 |
| 43 | FGFR2 | 0.89565796 |
| 44 | STK38L | 0.88919428 |
| 45 | PRKCE | 0.88608973 |
| 46 | MAP3K12 | 0.88562524 |
| 47 | NLK | 0.86244473 |
| 48 | CAMKK2 | 0.84656271 |
| 49 | ERBB2 | 0.83779550 |
| 50 | PRKACA | 0.83231921 |
| 51 | LATS1 | 0.82464168 |
| 52 | PRKCZ | 0.75030814 |
| 53 | PAK3 | 0.74058700 |
| 54 | SGK3 | 0.73826339 |
| 55 | PRKG1 | 0.73133920 |
| 56 | DAPK2 | 0.70729317 |
| 57 | MUSK | 0.70000794 |
| 58 | MAP2K6 | 0.67167673 |
| 59 | CSNK1D | 0.62475540 |
| 60 | BRSK2 | 0.62452010 |
| 61 | IRAK1 | 0.62247929 |
| 62 | TIE1 | 0.61928699 |
| 63 | ADRBK1 | 0.61896669 |
| 64 | ABL2 | 0.60397242 |
| 65 | PRKCB | 0.58532500 |
| 66 | RIPK1 | 0.57779628 |
| 67 | NEK9 | 0.57659734 |
| 68 | SGK1 | 0.55648889 |
| 69 | PRKCA | 0.55551289 |
| 70 | MYLK | 0.54423133 |
| 71 | EIF2AK3 | 0.53864075 |
| 72 | MAP3K2 | 0.52616933 |
| 73 | TRIM28 | 0.52154723 |
| 74 | CSNK1A1 | 0.52008409 |
| 75 | CSF1R | 0.51336551 |
| 76 | TBK1 | 0.45788999 |
| 77 | JAK1 | 0.45084372 |
| 78 | PDK2 | 0.44921384 |
| 79 | MAP3K3 | 0.44352859 |
| 80 | MAP3K5 | 0.44169766 |
| 81 | PRKACB | 0.44030705 |
| 82 | RPS6KA3 | 0.43101754 |
| 83 | MAP3K7 | 0.42937272 |
| 84 | PDK1 | 0.39299932 |
| 85 | PDPK1 | 0.38977499 |
| 86 | TEC | 0.38872911 |
| 87 | TNIK | 0.37797436 |
| 88 | TXK | 0.36494599 |
| 89 | ZAK | 0.35944064 |
| 90 | PRKCQ | 0.34919345 |
| 91 | CSNK1G1 | 0.34419886 |
| 92 | JAK2 | 0.33845649 |
| 93 | EIF2AK1 | 0.33403938 |
| 94 | MAP2K7 | 0.32810050 |
| 95 | ERBB3 | 0.32605200 |
| 96 | STK38 | 0.31764231 |
| 97 | CSNK1E | 0.31503461 |
| 98 | KIT | 0.31490518 |
| 99 | OBSCN | 0.31324738 |
| 100 | DYRK1A | 0.29942911 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Caffeine metabolism_Homo sapiens_hsa00232 | 4.58338160 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.08961838 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.85774695 |
| 4 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 3.61657287 |
| 5 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.58983101 |
| 6 | Retinol metabolism_Homo sapiens_hsa00830 | 3.37848533 |
| 7 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 3.36389175 |
| 8 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.91142113 |
| 9 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.85510342 |
| 10 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.72264613 |
| 11 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.70186278 |
| 12 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.65024576 |
| 13 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 2.61467694 |
| 14 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.34325647 |
| 15 | * Butanoate metabolism_Homo sapiens_hsa00650 | 2.22755831 |
| 16 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 2.17275595 |
| 17 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.16812398 |
| 18 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.09909664 |
| 19 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.07857840 |
| 20 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.96179133 |
| 21 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.94296266 |
| 22 | Histidine metabolism_Homo sapiens_hsa00340 | 1.80246829 |
| 23 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.78052905 |
| 24 | Bile secretion_Homo sapiens_hsa04976 | 1.77725934 |
| 25 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.77105355 |
| 26 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.51219088 |
| 27 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.49966749 |
| 28 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.47991801 |
| 29 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.45818620 |
| 30 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.45254716 |
| 31 | Peroxisome_Homo sapiens_hsa04146 | 1.40351305 |
| 32 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.38157636 |
| 33 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.34479424 |
| 34 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.26912851 |
| 35 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.26881039 |
| 36 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.23545213 |
| 37 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.20522717 |
| 38 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.14720166 |
| 39 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.12251180 |
| 40 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.09937265 |
| 41 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.04578040 |
| 42 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.98413885 |
| 43 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.96179665 |
| 44 | ABC transporters_Homo sapiens_hsa02010 | 0.95478201 |
| 45 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.94711641 |
| 46 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.93204579 |
| 47 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.79105605 |
| 48 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.78139056 |
| 49 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.78049544 |
| 50 | Carbon metabolism_Homo sapiens_hsa01200 | 0.69196372 |
| 51 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.67915778 |
| 52 | Prion diseases_Homo sapiens_hsa05020 | 0.62938888 |
| 53 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.62599915 |
| 54 | Lysine degradation_Homo sapiens_hsa00310 | 0.60471452 |
| 55 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.60321374 |
| 56 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.58813970 |
| 57 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.46563431 |
| 58 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.45555799 |
| 59 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.43429844 |
| 60 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.39619417 |
| 61 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.39042699 |
| 62 | Sulfur relay system_Homo sapiens_hsa04122 | 0.35767321 |
| 63 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.34843395 |
| 64 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.34348876 |
| 65 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.32578110 |
| 66 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.31794419 |
| 67 | Pertussis_Homo sapiens_hsa05133 | 0.20490133 |
| 68 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.16837773 |
| 69 | Insulin resistance_Homo sapiens_hsa04931 | 0.13874880 |
| 70 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.12655204 |
| 71 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.12111690 |
| 72 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.10262342 |
| 73 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.10120304 |
| 74 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.09997472 |
| 75 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.06588546 |
| 76 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.03899521 |
| 77 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.02440484 |
| 78 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.02385997 |
| 79 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.2370219 |
| 80 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | -0.2189459 |
| 81 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | -0.1875141 |
| 82 | Phototransduction_Homo sapiens_hsa04744 | -0.1872624 |
| 83 | Galactose metabolism_Homo sapiens_hsa00052 | -0.1785063 |
| 84 | GABAergic synapse_Homo sapiens_hsa04727 | -0.1778259 |
| 85 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | -0.1712855 |
| 86 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | -0.1371353 |
| 87 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.1356196 |
| 88 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1355079 |
| 89 | Circadian rhythm_Homo sapiens_hsa04710 | -0.1290747 |
| 90 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | -0.1201923 |
| 91 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.1110858 |
| 92 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.0847824 |
| 93 | Sphingolipid metabolism_Homo sapiens_hsa00600 | -0.0803480 |
| 94 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0747654 |
| 95 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.0590793 |
| 96 | Folate biosynthesis_Homo sapiens_hsa00790 | -0.0583558 |
| 97 | Pentose phosphate pathway_Homo sapiens_hsa00030 | -0.0482569 |
| 98 | Mineral absorption_Homo sapiens_hsa04978 | -0.0285175 |
| 99 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | -0.0203492 |
| 100 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.0090922 |

